New FDA framework points to boost for cell and gene therapies – BioPharma Dive
Genetic Literacy Project |
New FDA framework points to boost for cell and gene therapies
BioPharma Dive After decades of research, cell and gene therapies are finally emerging onto the marketplace and showing potential for regenerative medicine in serious conditions. Two cell-based gene therapies, Novartis AG's Kymriah (tisagenlecleucel) and Gilead … BioNews – FDA to speed up gene therapy and regenerative … Gene therapy boost: FDA positions for faster reviews of new treatments FDA Issues Final and Draft Regenerative Medicine Guidance … |
